HUTCHMED (China) HCM
NASDAQ HCM
$12.58 -0.01 (-0.08%)
As of: Aug 20, 2026 · 3:59 PM EDT

HUTCHMED (China) (HCM) Change in Acquisitions & Divestments (2018 - 2021)

HUTCHMED (China) (HCM) posted quarterly Change in Acquisitions & Divestments of $50.0 million for Q2 2021, down 73.95% year-over-year from $191.8 million in Q2 2020, and down 74.97% quarter-over-quarter from $199.5 million in Q1 2021.

HUTCHMED (China) (HCM) Change in Acquisitions & Divestments (2018 - 2021) Analysis & Trends

HUTCHMED (China) (HCM) has reported Change in Acquisitions & Divestments for 4 consecutive years, with $50.0 million the latest figure, recorded in Q2 2021.

  • In Q2 2021, Change in Acquisitions & Divestments fell 73.95% year-over-year to $50.0 million; the TTM figure through Jun 2021 stood at $537.3 million (up 8.6% YoY), while the FY2025 annual figure was $2.1 billion, up 20.29% from the prior year.
  • Change in Acquisitions & Divestments slipped to $50.0 million in Q2 2021 per HCM's latest filing, from $199.5 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $273.0 million in Q1 2018 and bottomed at $50.0 million in Q2 2021.
  • Historically, Change in Acquisitions & Divestments has averaged $174.7 million across 4 years, with a median of $195.7 million in 2020.
  • On a YoY basis, Change in Acquisitions & Divestments climbed as much as 107.84% in 2021 and fell as far as 73.95% in 2021.
  • HUTCHMED (China)'s Change in Acquisitions & Divestments stood at $202.4 million in 2018, then tumbled by 70.4% to $59.9 million in 2019, then soared by 220.0% to $191.8 million in 2020, then tumbled by 73.95% to $50.0 million in 2021.
  • Business Quant data shows HCM's Change in Acquisitions & Divestments at $50.0 million in Q2 2021, $199.5 million in Q1 2021, and $191.8 million in Q2 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.83 Bn 42.86 Bn -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn -
10 HUTCHMED (China) 2.18 Bn 2.18 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2021 49.95 Mn
Jun 30, 2021 49.95 Mn
Mar 31, 2021 199.55 Mn
Mar 31, 2021 199.55 Mn
Jun 30, 2020 191.76 Mn
Jun 30, 2020 191.76 Mn
Mar 31, 2020 96.01 Mn
Mar 31, 2020 96.01 Mn
Dec 31, 2019 59.93 Mn
Dec 31, 2019 59.93 Mn
Sep 30, 2019 147.03 Mn
Sep 30, 2019 147.03 Mn
Jun 30, 2019 180.17 Mn
Jun 30, 2019 180.17 Mn
Mar 31, 2019 209.92 Mn
Mar 31, 2019 209.92 Mn
Dec 31, 2018 202.44 Mn
Dec 31, 2018 202.44 Mn
Sep 30, 2018 242.19 Mn
Sep 30, 2018 242.19 Mn